| scholarly article | Q13442814 |
| P2093 | author name string | E Kreisler | |
| R Frago | |||
| S Biondo | |||
| D Fraccalvieri | |||
| L Trenti | |||
| T Golda | |||
| P2860 | cites work | Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy | Q85447812 |
| Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: a phase II study | Q85648701 | ||
| Impact of a multidisciplinary team training programme on rectal cancer outcomes in Spain | Q85958408 | ||
| No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT) | Q86122626 | ||
| Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer | Q86500529 | ||
| Neoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized study | Q86604304 | ||
| Multicentre propensity score-matched analysis of conventional versus extended abdominoperineal excision for low rectal cancer | Q87853755 | ||
| Postoperative adjuvant chemotherapy in rectal cancer operated for cure | Q24201072 | ||
| The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline | Q24798895 | ||
| The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? | Q29300453 | ||
| Cancer treatment and survivorship statistics, 2014 | Q29617702 | ||
| Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data | Q30884451 | ||
| Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial | Q33417569 | ||
| Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data | Q33545524 | ||
| Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data | Q33652239 | ||
| International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams. | Q34173100 | ||
| Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients | Q34534153 | ||
| Preoperative versus postoperative chemoradiotherapy for rectal cancer | Q34552041 | ||
| Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921. | Q34559198 | ||
| Chemotherapy with preoperative radiotherapy in rectal cancer | Q34570877 | ||
| Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer | Q34571028 | ||
| Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. | Q34571372 | ||
| Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial | Q34607843 | ||
| Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. | Q34643037 | ||
| Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study | Q34659103 | ||
| Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial | Q34761643 | ||
| Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial | Q35046474 | ||
| Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis. | Q35481618 | ||
| A Systematic Overview of Radiation Therapy Effects in Rectal Cancer | Q35574859 | ||
| Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer | Q36554284 | ||
| Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients | Q37119089 | ||
| Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. | Q37158196 | ||
| Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation. | Q37238569 | ||
| Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysis | Q37404742 | ||
| Current neoadjuvant strategies in rectal cancer | Q37699142 | ||
| Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials | Q37709739 | ||
| Point: short-course radiation therapy is preferable in the neoadjuvant treatment of rectal cancer | Q37885522 | ||
| Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy? | Q37955677 | ||
| Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature | Q38112258 | ||
| EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum | Q38158829 | ||
| Multiparametric MRI of rectal cancer in the assessment of response to therapy: a systematic review | Q38210155 | ||
| Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control | Q38432466 | ||
| Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer | Q39689132 | ||
| Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point | Q39717585 | ||
| Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial | Q39748379 | ||
| Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? | Q40384363 | ||
| Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. | Q40392520 | ||
| Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial | Q41572461 | ||
| Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. | Q42773841 | ||
| Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy | Q43836282 | ||
| Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. | Q44045712 | ||
| Laparoscopic versus open surgery for rectal cancer: results of a prospective multicentre analysis of 4,970 patients | Q44922791 | ||
| Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy | Q45034895 | ||
| Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. | Q45071422 | ||
| Local recurrence in rectal cancer: anatomic localization and effect on radiation target | Q45260284 | ||
| Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer | Q45712707 | ||
| Late assessment of local control by PET in patients with distal rectal cancer managed non-operatively after complete tumor regression following neoadjuvant chemoradiation. | Q46559443 | ||
| A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial | Q47096957 | ||
| Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial | Q50000489 | ||
| Late adverse effects of short-course preoperative radiotherapy in rectal cancer. | Q53221815 | ||
| Multicenter study of outcome in relation to the type of resection in rectal cancer. | Q53533159 | ||
| Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer. | Q53558917 | ||
| Specialized Referral Centers for Rectal Cancer. | Q54567006 | ||
| Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial | Q57560962 | ||
| Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer† | Q61481005 | ||
| The TME Trial After a Median Follow-up of 6 Years | Q61481329 | ||
| Dose-volume correlation in radiation-related late small-bowel complications: a clinical study | Q68608830 | ||
| Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects | Q70733385 | ||
| Preoperative radiotherapy in rectal carcinoma--aspects of acute adverse effects and radiation technique | Q71379439 | ||
| Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials | Q71466210 | ||
| Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer | Q72240697 | ||
| Improved survival with preoperative radiotherapy in resectable rectal cancer | Q73199939 | ||
| Preoperative radiotherapy for resectable rectal cancer: A meta-analysis | Q74177972 | ||
| Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study | Q74566203 | ||
| Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial | Q79374099 | ||
| Clinical target volume for rectal cancer: in regard to Roels et al. (Int J Radiat Oncol Biol Phys 2006;65:1129-1142) | Q80193209 | ||
| Systemic treatment of colorectal cancer | Q81253030 | ||
| In regards to Bujko et Al. (Int j radiat oncol biol phys 2007;68:313-316) | Q81298501 | ||
| Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial | Q81545753 | ||
| Adjuvant chemotherapy for rectal cancer | Q82562908 | ||
| Quality of mesorectum after laparoscopic resection for rectal cancer - results of an audited teaching programme in Spain | Q83254446 | ||
| Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer | Q83292305 | ||
| Laparoscopic total mesorectal excision following long course chemoradiotherapy for locally advanced rectal cancer | Q84010868 | ||
| A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management? | Q84738397 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 145-152 | |
| P577 | publication date | 2016-01-12 | |
| P1433 | published in | Techniques in Coloproctology | Q15766606 |
| P1476 | title | Update on advances and controversy in rectal cancer treatment | |
| P478 | volume | 20 |
| Q42130502 | Focusing the management of rectal cancer. | cites work | P2860 |
Search more.